RASINI, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 5.061
EU - Europa 2.267
AS - Asia 1.647
SA - Sud America 286
Continente sconosciuto - Info sul continente non disponibili 53
AF - Africa 40
OC - Oceania 1
Totale 9.355
Nazione #
US - Stati Uniti d'America 4.993
IT - Italia 869
SG - Singapore 483
CN - Cina 404
UA - Ucraina 334
SE - Svezia 267
BR - Brasile 247
VN - Vietnam 246
TR - Turchia 215
DE - Germania 192
HK - Hong Kong 142
FI - Finlandia 124
GB - Regno Unito 115
IE - Irlanda 99
FR - Francia 98
RU - Federazione Russa 59
IN - India 40
BD - Bangladesh 33
MX - Messico 33
JP - Giappone 30
CA - Canada 28
PL - Polonia 22
ZA - Sudafrica 17
AR - Argentina 16
ES - Italia 16
CZ - Repubblica Ceca 14
BE - Belgio 12
NL - Olanda 10
AT - Austria 9
RO - Romania 8
EC - Ecuador 7
IQ - Iraq 7
NG - Nigeria 7
AE - Emirati Arabi Uniti 6
EU - Europa 5
MA - Marocco 5
PK - Pakistan 5
CO - Colombia 4
JO - Giordania 4
LT - Lituania 4
SA - Arabia Saudita 4
CL - Cile 3
EG - Egitto 3
IL - Israele 3
PY - Paraguay 3
VE - Venezuela 3
AL - Albania 2
BO - Bolivia 2
CH - Svizzera 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
Totale 9.308
Città #
Dallas 1.008
Milan 529
Chandler 397
Ashburn 326
San Jose 324
Singapore 315
Fairfield 287
Woodbridge 256
Jacksonville 255
Ann Arbor 220
Hong Kong 139
Houston 129
Beijing 128
Seattle 128
Wilmington 115
Nyköping 108
The Dalles 99
Dublin 98
Cambridge 96
Council Bluffs 93
Princeton 88
Izmir 87
Dearborn 73
Los Angeles 71
Como 70
New York 68
Dong Ket 65
Boardman 54
Rome 51
Helsinki 47
Lauterbourg 44
Munich 44
Hanoi 40
Ho Chi Minh City 40
Chicago 38
San Mateo 38
London 33
Frankfurt am Main 30
Tokyo 30
Des Moines 28
San Diego 27
Buffalo 26
Santa Clara 25
Orem 24
Varese 24
Chennai 22
Mexico City 20
São Paulo 20
Warsaw 20
Denver 17
Ogden 17
Johannesburg 16
Montreal 14
Poplar 14
Atlanta 13
Brno 13
Brussels 12
Brooklyn 11
Guangzhou 11
Phoenix 11
Stockholm 11
Washington 11
Berlin 10
Shanghai 9
Düsseldorf 8
Querétaro 8
Abuja 7
Amsterdam 7
Brasília 7
Columbus 7
Haiphong 7
Hangzhou 7
Manchester 7
Norwalk 7
San Francisco 7
Stuttgart 7
Tianjin 7
Hefei 6
Ponte Lambro 6
Shenzhen 6
Ankara 5
Boston 5
Rio de Janeiro 5
Shenyang 5
Verona 5
Vienna 5
West Jordan 5
Amman 4
Biên Hòa 4
Casorezzo 4
Da Nang 4
Franca 4
Guarulhos 4
Jinan 4
Miami 4
Recife 4
Redmond 4
Redwood City 4
Salvador 4
Sumaré 4
Totale 6.685
Nome #
1-year statin treatment reverts the pro-inflammatory cytokine interleukin-8 release of primed neutrophils in dyslipidemic subjects 1.171
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 275
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 232
Isoflavone content and estrogenic activity of different batches of red clover (Trifolium pratense L.) extracts: An in vitro study in MCF-7 cells 229
Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. 228
Peripheral CD4+CD25+ Regulatory T-cell Frequency is Increased in High-Cardiovascular-Risk Subjects and is not Modified after 1-month Statin Treatment: a Longitudinal Study. 221
7-hydroxymatairesinol potassium acetate (Hmr/LignanTM) from Norway spruce (Picea abies) knots and its active metabolite enterolactone exert estrogenic effects in the in MCF-7 cell model. 219
Characterization of human leukocyte-HUVEC adhesion: Effect of cell preparation methods 219
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study 218
Association between the circadian course of endogenous noradrenaline and the hematopoietic cell cycle in mouse bone marrow. 214
Dopaminergic D-1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes 214
Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignantrade mark) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells. 212
Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection? 212
Dopaminergic inhibition of human neutrophils is exerted through D1-like receptors and affected by bacterial infection 210
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up 204
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment 204
Production of proinflammatory mediators by human neutrophils during long-term culture 202
cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms 202
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 196
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: Evidence for a D1-like receptor-dependent protective effect 194
Atorvastatin treatment influences polymorphonuclear leukocyte function: a longitudinal study. 178
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment 177
Effects of atorvastatin treatment on the modulation of leukocyte function in patients undergoing peripheral vascular intervention: a longitudinal study 175
Angiotensin II Type1 and type2 receptor expression in circulating monocytes of diabetic patients over 3-month rosuvastatin treatment 175
Treatment with simvastatin modifies AT1R expression and function in polymorphonuclear leukocyte of high cardiovascular risk subjects: a longitudinal study 173
Il trattamento con rosuvastatina è associato ad una riduzione dell’espressione del recettore di tipo 1, ma non di tipo 2, dell’Angiotensina II in monociti circolanti di pazienti diabetici. 166
Patients with type 2 diabetes vs. non-diabetic high-risk subjects: effect of simvastatin on angiotensin II type 1 receptor mRNA expression in leukocytes 161
Angiotensin II Reduces the Suppressive Function of Human CD4+CD25+ Regulatory T Lymphocytes. 161
Endothelial cell dysfunction in patients with peripheral artery disease. 160
Effect of interferon-beta on endogenous catecholamines in human peripheral blood mononuclear cells: interaction with interferon-gamma and relevance for activation-induced apoptosis 159
Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis 159
Beta1- and Beta2-Adrenoceptors Expression Patterns in Human Non-small Cell Lung Cancer: Relationship with Cancer Histology 154
Angiotensin type1 receptor expression and Interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral artery disease. 152
Caratteristiche funzionali dei leucociti polimorfonucleati in pazienti dislipidemici: modificazione a 1 mese ed 1 anno di trattamento con simvastatina. 148
Effecys of Natalizumab on CD4+CD25+FoxP3+ regulatory T lymphocytes in multiple sclerosis patients 147
Terapia con statina in pazienti dislipidemici affetti da steatoepatite non alcolica: effetto su lipidi e funzione epatica. 146
Longitudinal evaluation of endogenous catecholamines and activation-induced apoptosis in lymphocytes from multiple sclerosis patients undergoing interferon-beta treatment 142
Reactive oxygen species generation and AT1-receptors during prolonged simvastatin treatment in neutrophils by dyslipidemic subjects 141
Interferon beta reverts the effects of interferon gamma on endogenous catecholamines produced by blood mononuclear cells from multiple sclerosis patients 138
effect of simvastatin on angiotensin II type 1 receptor mRNA expression in leukocytes: a longitudinal study in dyslipidemic subjects. 131
Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease 126
Interferon-beta and interferon-gamma affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis. 121
Expression of the ANG II Type 1 Receptor on human CD4+CD25+hi regulatory T cells 119
A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1) 112
Reduction of Angiotensin II type 1 receptor mRNA expression on human leukocyte subsets after simvastatin treatment in high-risk patients 112
Dopaminergic modulation of CD4+CD25high regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy 108
Do Th17 lymphocytes and IL-17 contribute to Parkinson's disease? A systematic review of available evidence 75
Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors 69
Effect of Cannabidiol on Human Peirpheral Blood Mononuclear Cells and CD4+ T Cells. 63
Modified Mediterranean diet effects on Parkinson’s disease (MED-PARK): a single-centre randomised controlled trial protocol 31
Totale 9.355
Categoria #
all - tutte 32.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022471 0 71 45 42 36 8 24 22 29 77 57 60
2022/2023930 76 98 57 139 36 183 8 146 112 21 36 18
2023/2024966 132 125 143 194 169 103 1 15 22 13 15 34
2024/20251.000 17 25 150 58 34 56 84 73 71 115 111 206
2025/20263.190 221 334 783 384 304 179 434 148 173 124 64 42
2026/2027149 43 106 0 0 0 0 0 0 0 0 0 0
Totale 9.355